Max Colao

CEO at OncoVerity

Speaker

Max Colao, MBA, is the founding Chief Executive Officer of OncoVerity, bringing over 30 years of biotechnology leadership to the role. Prior to OncoVerity, he served as Chief Commercial Officer at Aurinia, where he built and led the commercial team through a successful launch. His extensive experience also includes progressively senior roles at Alexion, where he headed U.S. commercial operations and spearheaded multiple rare disease therapy launches. He also dedicated two decades at Amgen, holding senior positions and launching numerous therapies in hematology, oncology, and autoimmune disorders, contributing to Amgen's evolution from a small biotech into a pharmaceutical powerhouse.